Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 1
2019 5
2020 2
2021 4
2022 2
2023 4
2024 8
2025 10
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Ex vivo venetoclax sensitivity predicts clinical response in acute myeloid leukemia in the prospective VenEx trial.
Kytölä S, Vänttinen I, Ruokoranta T, Partanen A, Holopainen A, Saad J, Kuusisto MEL, Koskela S, Räty R, Itälä-Remes M, Västrik I, Suvela M, Parsons A, Porkka K, Wennerberg K, Heckman CA, Jalkanen T, Huttunen T, Ettala P, Rimpiläinen J, Siitonen T, Pyörälä M, Kuusanmäki H, Kontro M. Kytölä S, et al. Among authors: kuusisto mel. Blood. 2025 Jan 23;145(4):409-421. doi: 10.1182/blood.2024024968. Blood. 2025. PMID: 39357056 Free PMC article. Clinical Trial.
Capillary Sampling Enables Venetoclax Concentration Measurement in Acute Myeloid Leukaemia Within Academic Multicentre Trial.
Kytölä S, Kurkela M, Kiiski JI, Vänttinen I, Ruokoranta T, Partanen A, Holopainen A, Pyörälä M, Kuusisto MEL, Siitonen T, Koskela S, Rimpiläinen J, Ettala P, Kuusanmäki H, Niemi M, Backman JT, Kontro M. Kytölä S, et al. Among authors: kuusisto mel. Basic Clin Pharmacol Toxicol. 2025 Jun;136(6):e70041. doi: 10.1111/bcpt.70041. Basic Clin Pharmacol Toxicol. 2025. PMID: 40289318
Link between disease status at 24 months and mortality in follicular lymphoma.
Rajamäki A, Hujo M, Sund R, Prusila REI, Kuusisto MEL, Kuitunen H, Jantunen E, Mercadal S, Sorigue M, Sancho JM, Kuittinen O, Sunela K. Rajamäki A, et al. Among authors: kuusisto mel. Br J Haematol. 2022 Nov;199(3):458-462. doi: 10.1111/bjh.18423. Epub 2022 Aug 26. Br J Haematol. 2022. PMID: 36028946 No abstract available.
Ex vivo venetoclax sensitivity testing predicts treatment response in acute myeloid leukemia.
Kuusanmäki H, Kytölä S, Vänttinen I, Ruokoranta T, Ranta A, Huuhtanen J, Suvela M, Parsons A, Holopainen A, Partanen A, Kuusisto MEL, Koskela S, Räty R, Itälä-Remes M, Västrik I, Dufva O, Siitonen S, Porkka K, Wennerberg K, Heckman CA, Ettala P, Pyörälä M, Rimpiläinen J, Siitonen T, Kontro M. Kuusanmäki H, et al. Among authors: kuusisto mel. Haematologica. 2023 Jul 1;108(7):1768-1781. doi: 10.3324/haematol.2022.281692. Haematologica. 2023. PMID: 36519325 Free PMC article.
35 results